Medpace Holdings President and CEO August J. Troendle sold approximately $27.4 million worth of company stock over two days. The transactions were disclosed in a Form 4 filing on September 25, 2026, and reported by news outlets on September 26.
On September 23, Troendle sold 16,083 shares. They fetched a weighted average price of $628.64.
On September 24, he sold another 27,833 shares. They fetched a weighted average price of $621.33.
After the sales, Troendle held 389,456 shares directly. He also maintained an indirect holding of more than 4.7 million shares through Medpace Investors, LLC.
The sales were executed through a limit order placed during an open trading window.